ArticleJMIR research protocols2026

Tripterygium Glycoside Tablets Combined With Conventional Synthetic Disease-Modifying Antirheumatic Drugs for Treating Rheumatoid Arthritis: Protocol for a Prospective, Multicenter, Open-Label Randomized Controlled Trial.

Liu Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.